Neuroendocrine predominance and immunosuppression characterize small-cell lung cancer.
Findings could pave the way for developing new treatment options.
Analysis using single-cell RNA sequencing highlights critical molecular characteristics.
Support for further research into targeted therapies tailored to this cancer type.
Abstract
Our knowledge of the basic traits of SCLC is improved by this highly accurate single-cell study, which also offers fresh suggestions for potential future therapies.